EUCTR2005-006172-35-GB进行中（未招募）1 期
A Randomised, Prospective, Double Blinded, Placebo Controlled Trial to Determine the Efficacy of Continuous Infusion Ankle Block Compared to Standard Single Bolus Block in the Management of Postoperative Pain Following Foot and Ankle Surgery - Ankle Block Study
orth Hampshire Hospital NHS Trust0 个研究点目标入组 56 人开始时间: 2006年4月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients listed for ankle and hindfoot surgery under Mr. James Calder.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Peripheral neuropathy
- •Inability to fill in questionnaires (e.g. dementia)
研究者
相似试验
已完成
不适用
A Randomised, Prospective, Double Blinded, Placebo Controlled Trial to Determine the Efficacy of Continuous Infusion Ankle Block Compared to Standard Single Bolus Block in the Management of Postoperative Pain Following Foot and Ankle SurgeryISRCTN57941461Record Provided by the NHSTCT Register - 2006 Update - Department of Health56
已完成
不适用
Study of nutraceutical formulation in healthy subjects with mild damage of lung function due to long term exposure to polluted environment.CTRI/2018/10/016195Amway India Enterprises Pvt Ltd56
已完成
不适用
A study to assess effects of Nutraceutical formulations in Pre-diabetic Subjects.CTRI/2018/09/015586Amway India Enterprises Pvt Ltd56
进行中（未招募）
1 期
Planned, randomized trial where placebo is used and the drug. No one would know which subject has the drug and which one has placebo. Trial is phase 3 study and will study how safe and effective the drug is with subjects who have Advanced or Metastatic Gastric Cancer (GC)Advanced or Metastatic Gastric CancerEUCTR2016-003984-20-PLSK BioPartners, Inc459
进行中（未招募）
1 期
Planned, randomized trial where placebo is used and the drug. No one would know which subject has the drug and which one has placebo. Trial is phase 3 study and will study how safe and effective the drug is with subjects who have Advanced or Metastatic Gastric Cancer (GC)Advanced or Metastatic Gastric CancerEUCTR2016-003984-20-DEElevar Therapeutics, Inc459